Nutritional Composition for Deiodinase 1 Support in Low fT3/fT4
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nutritional strategies fail to address the specific metabolic imbalance in cancer patients and elderly subjects characterized by a low fT3/fT4 ratio, leading to malnutrition, muscle wasting, and poor prognosis, with no existing supplements targeting the peripheral conversion of thyroid hormones.
Innovation Solution
A nutritional supplement comprising vitamin A, resveratrol, monounsaturated fatty acids, taurine, and selenium is designed to support deiodinase 1 enzyme activity, enhance immune function, and reduce inflammation, thereby promoting optimal fT4 to fT3 conversion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional nutritional strategies are used, then general nutritional intake is improved, but the specific metabolic imbalance (low fT3/fT4 ratio) is not addressed
Solution Approach 1:
The supplement targets specific nutrients (selenium, zinc, iron, vitamins) that directly influence deiodinase enzyme activity and thyroid hormone conversion, rather than providing general nutrition. This localized approach addresses the specific metabolic imbalance in the thyroid hormone pathway while maintaining overall nutritional support.
Solution Approach 2:
The supplement aims to change the fT3/fT4 ratio parameter by providing cofactors that enhance deiodinase activity. By modifying the biochemical parameters of thyroid hormone conversion through targeted nutrient supplementation, the metabolic balance is restored without altering general caloric intake.
2Ease of operation
If no specific intervention is provided, then treatment simplicity is maintained, but muscle wasting and malnutrition progress
Solution Approach 1:
The supplement is designed to be administered early in the disease course to prevent muscle wasting and malnutrition before they become severe. By providing deiodinase cofactors proactively, the treatment prevents the development of cachexia rather than treating established muscle loss, maintaining simplicity while preserving muscle mass.
3Use of energy by moving object
If general nutritional support is provided, then caloric needs are met, but thyroid hormone conversion efficiency is not enhanced
Solution Approach 1:
The supplement introduces intermediary substances (selenium, zinc, iron, vitamins) that act as cofactors for deiodinase enzymes. These intermediaries facilitate the conversion of T4 to T3 by providing necessary biochemical components, thereby enhancing hormone conversion efficiency without directly altering caloric intake or thyroid hormone levels themselves.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The supplement effectively maintains a balanced thyroid hormone ratio, improving metabolic status, enhancing muscle trophism, and bolstering immune response in vulnerable populations.
Implementation Method 1
support deiodinase 1 enzyme activity, enhance immune function, and reduce inflammation, thereby promoting optimal fT4 to fT3 conversion
Data Source
AI summary
The invention relates to the nutritional supplementation of a specific category of cancer patients or elderly subjects as defined by low levels of serum fT3/fT4 ratio. The supplement is made of specific dosages of vitamin A, resveratrol, oleic acid, taurine and selenium combined to synergistically act for increasing fT4 to fT3 hormones peripheral conversion operated by deiodinase 1 enzyme by stimulating its expression and to provide an optimal metabolic support to subjects at high risk of nutrition-related worsening of their clinical conditions.